Heart Test Laboratories (HSCS) Competitors $2.90 -0.04 (-1.36%) (As of 11/1/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends HSCS vs. CTCX, CHEK, NUVO, NDRA, STSS, AEMD, INBS, AFIB, SONX, and QNRXShould you be buying Heart Test Laboratories stock or one of its competitors? The main competitors of Heart Test Laboratories include Carmell (CTCX), Check-Cap (CHEK), Holdco Nuvo Group D.G (NUVO), ENDRA Life Sciences (NDRA), Sharps Technology (STSS), Aethlon Medical (AEMD), Intelligent Bio Solutions (INBS), Acutus Medical (AFIB), Sonendo (SONX), and Quoin Pharmaceuticals (QNRX). These companies are all part of the "medical equipment" industry. Heart Test Laboratories vs. Carmell Check-Cap Holdco Nuvo Group D.G ENDRA Life Sciences Sharps Technology Aethlon Medical Intelligent Bio Solutions Acutus Medical Sonendo Quoin Pharmaceuticals Heart Test Laboratories (NASDAQ:HSCS) and Carmell (NASDAQ:CTCX) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment, community ranking and earnings. Which has preferable valuation and earnings, HSCS or CTCX? Heart Test Laboratories has higher revenue and earnings than Carmell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHeart Test Laboratories$20K131.95-$6.61M-$21.64-0.13Carmell$12.32K551.47-$15.44MN/AN/A Does the MarketBeat Community prefer HSCS or CTCX? Heart Test Laboratories received 4 more outperform votes than Carmell when rated by MarketBeat users. CompanyUnderperformOutperformHeart Test LaboratoriesOutperform Votes480.00% Underperform Votes120.00% CarmellN/AN/A Do insiders and institutionals hold more shares of HSCS or CTCX? 17.2% of Heart Test Laboratories shares are held by institutional investors. Comparatively, 24.2% of Carmell shares are held by institutional investors. 1.8% of Heart Test Laboratories shares are held by insiders. Comparatively, 29.0% of Carmell shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term. Which has more volatility and risk, HSCS or CTCX? Heart Test Laboratories has a beta of 3.16, suggesting that its stock price is 216% more volatile than the S&P 500. Comparatively, Carmell has a beta of 0.3, suggesting that its stock price is 70% less volatile than the S&P 500. Is HSCS or CTCX more profitable? Heart Test Laboratories' return on equity of -144.12% beat Carmell's return on equity.Company Net Margins Return on Equity Return on Assets Heart Test LaboratoriesN/A -144.12% -94.48% Carmell N/A -148.47%-40.47% Do analysts recommend HSCS or CTCX? Heart Test Laboratories currently has a consensus price target of $15.00, indicating a potential upside of 417.24%. Given Heart Test Laboratories' higher possible upside, analysts plainly believe Heart Test Laboratories is more favorable than Carmell.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Heart Test Laboratories 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Carmell 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) N/A Does the media favor HSCS or CTCX? In the previous week, Heart Test Laboratories' average media sentiment score of 0.00 beat Carmell's score of -1.00 indicating that Heart Test Laboratories is being referred to more favorably in the media. Company Overall Sentiment Heart Test Laboratories Neutral Carmell Negative SummaryHeart Test Laboratories beats Carmell on 8 of the 12 factors compared between the two stocks. Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Get Heart Test Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for HSCS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HSCS vs. The Competition Export to ExcelMetricHeart Test LaboratoriesSurgical appliances & supplies IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.64M$9.81B$5.40B$8.53BDividend YieldN/A1.09%5.15%4.14%P/E Ratio-0.1319.53112.5515.07Price / Sales131.9540.481,478.8293.55Price / CashN/A25.5539.8334.04Price / Book0.265.774.645.01Net Income-$6.61M$181.29M$119.13M$225.46M7 Day Performance-6.39%-3.10%0.78%0.37%1 Month Performance-38.03%-7.14%5.65%3.57%1 Year Performance-86.26%2.36%36.90%29.42% Heart Test Laboratories Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HSCSHeart Test Laboratories3.217 of 5 stars$2.90-1.4%$15.00+417.2%-87.4%$2.64M$20,000.00-0.1310Positive NewsCTCXCarmell1.0637 of 5 stars$0.33-2.9%N/A-83.8%$6.98M$12,320.000.0014Negative NewsCHEKCheck-Cap0.2746 of 5 stars$1.19+0.8%N/A-66.2%$6.98MN/A-0.4080Analyst ForecastNews CoverageNUVOHoldco Nuvo Group D.GN/A$0.17-23.6%N/AN/A$5.65M$180,000.000.00N/ANDRAENDRA Life Sciences3.1822 of 5 stars$0.33+18.1%$20,000.00+6,119,851.0%-100.0%$5.65MN/A-0.0120High Trading VolumeSTSSSharps Technology1.131 of 5 stars$3.01+9.5%N/AN/A$5.42MN/A-0.293News CoverageGap DownAEMDAethlon Medical2.7867 of 5 stars$0.39+2.6%$7.00+1,698.6%-73.5%$5.41M$570,000.00-0.1010Analyst ForecastNews CoverageINBSIntelligent Bio Solutions0.4422 of 5 stars$1.52-4.4%N/A-51.7%$4.74M$3.11M-0.0410News CoverageAFIBAcutus MedicalN/A$0.14-6.5%N/A-69.4%$4.62M$7.16M0.00340Gap DownSONXSonendo1.3946 of 5 stars$0.05flat$1.88+3,976.1%-84.1%$3.85M$43.87M-0.10250QNRXQuoin Pharmaceuticals3.1494 of 5 stars$0.88flat$4.00+354.4%-81.9%$3.50MN/A-0.164News CoverageGap Up Related Companies and Tools Related Companies Carmell Competitors Check-Cap Competitors Holdco Nuvo Group D.G Competitors ENDRA Life Sciences Competitors Sharps Technology Competitors Aethlon Medical Competitors Intelligent Bio Solutions Competitors Acutus Medical Competitors Sonendo Competitors Quoin Pharmaceuticals Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:HSCS) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Heart Test Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Heart Test Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
